NASDAQ:PRME | Free Cash Flow | Prime Medicine, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$42.71M$214,000.00-$42.92M
2025-12-31-$37.26M$290,000.00-$37.55M
2025-03-31-$48.86M$2.42M-$51.28M
2024-12-31$16.25M$1.79M$14.45M
2024-03-31-$67.71M$2.32M-$70.03M
2023-12-31-$43.86M$1.84M-$45.7M
2023-03-31-$41.56M$2M-$43.56M
2022-12-31-$30.71M$4.81M-$35.53M
2022-03-31-$50.79M$1.69M-$52.48M
2021-12-31-$13.19M$382,000.00-$13.57M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$162.56M$4.53M-$167.1M
2024-12-31-$122.87M$7.29M-$130.16M
2023-12-31-$165.41M$8.72M-$174.14M
2022-12-31-$131.83M$16.1M-$147.92M
2021-12-31-$34.08M$4.15M-$38.23M
2020-12-31-$5.54M$639,000.00-$6.18M